siRNA treatment reduces triglycerides in individuals with unusual problem

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran decreased triglyceride amounts by 80% as well as reduced the risk of pancreatitis in people with consistent chylomicronemia, along with or without a genetic diagnosis.